AKOS BBS-00005384
![]() |
- $126 - $349
- Product name: AKOS BBS-00005384
- CAS: 364744-50-3
- MF: C17H14Cl3N5
- MW: 394.69
- EINECS:
- MDL Number:MFCD01949876
- Synonyms:AKOS BBS-00005384;6-Chloro-N,N'-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine;[4-chloro-6-[(5-chloro-2-methyl-phenyl)amino]-s-triazin-2-yl]-(5-chloro-2-methyl-phenyl)amine;STK006843;ZINC02282401;ASISCHEM C34006;6-Chloro-N2,N4-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine;1,3,5-Triazine-2,4-diamine, 6-chloro-N2,N4-bis(5-chloro-2-methylphenyl)-
3 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11135128
- Product description6-Chloro-N2,N4-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine 97%
- Packaging5g
- Price$349
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number080747
- Product description6-Chloro-N,N'-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine
- Packaging500mg
- Price$126
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number080747
- Product description6-Chloro-N,N'-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine
- Packaging1g
- Price$158
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11135128 | 6-Chloro-N2,N4-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine 97% | 5g | $349 | 2021-12-16 | Buy |
Matrix Scientific | 080747 | 6-Chloro-N,N'-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine | 500mg | $126 | 2021-12-16 | Buy |
Matrix Scientific | 080747 | 6-Chloro-N,N'-bis(5-chloro-2-methylphenyl)-1,3,5-triazine-2,4-diamine | 1g | $158 | 2021-12-16 | Buy |
Properties
Boiling point :559.4±60.0 °C(Predicted)
Density :1.464±0.06 g/cm3(Predicted)
pka :2.58±0.10(Predicted)
Density :1.464±0.06 g/cm3(Predicted)
pka :2.58±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|